A carregar...
Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
CD19 is overexpressed in most human B cell malignancies and considered an important tumor marker for diagnosis and treatment. Aptamers are oligonucleotides that may potentially serve as tumor-homing ligand for targeted cancer therapy with excellent affinity and specificity. In this study, we selecte...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003574/ https://ncbi.nlm.nih.gov/pubmed/29928472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24902 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|